Jan Frystyk (J Frystyk)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Insulin Resistance

Top Venues

Scientific reports

European journal of pediatrics

Journal of the Endocrine Society

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

J B Holm, E Baggesen, Deirdre P Cronin-Fenton, Jan Frystyk, Jens Meldgaard Bruun, Peer M Christiansen, Signe Borgquist
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific reports 14 (1) (2024)
Michael M Richter, Mads N Thomsen, Mads J Skytte, Sasha A S Kjeldsen, Amirsalar Samkani, Jan Frystyk, Faidon Magkos, Jens J Holst, Sten Madsbad, Thure Krarup, Steen B Haugaard, Nicolai J Wewer Albrechtsen
Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes. Journal of the Endocrine Society 8 (4) (2024)
Anders Juul, Philippe F Backeljauw, Michael Højby Rasmussen, Jan Frystyk, Masanobu Kawai, Rasmus Juul Kildemoes, Anders Krogh Lemminger, Agnès Linglart, Nehama Zuckerman Levin, Reiko Horikawa
Somapacitan in Children Born SGA: 52-week Efficacy, Safety, and IGF-I Response Results from the Phase 2 REAL5 Study. The Journal of clinical endocrinology and metabolism (2024)
J B Holm, E Baggesen, Deirdre P Cronin-Fenton, Jan Frystyk, Jens Meldgaard Bruun, Peer M Christiansen, Signe Borgquist
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific reports 14 (1) (2024)
J B Holm, E Baggesen, Deirdre P Cronin-Fenton, Jan Frystyk, Jens Meldgaard Bruun, Peer M Christiansen, Signe Borgquist
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific reports 14 (1) (2024)
J B Holm, E Baggesen, Deirdre P Cronin-Fenton, Jan Frystyk, Jens Meldgaard Bruun, Peer M Christiansen, Signe Borgquist
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific reports 14 (1) (2024)
J B Holm, E Baggesen, Deirdre P Cronin-Fenton, Jan Frystyk, Jens Meldgaard Bruun, Peer M Christiansen, Signe Borgquist
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific reports 14 (1) (2024)
Michael M Richter, Mads N Thomsen, Mads J Skytte, Sasha A S Kjeldsen, Amirsalar Samkani, Jan Frystyk, Faidon Magkos, Jens J Holst, Sten Madsbad, Thure Krarup, Steen B Haugaard, Nicolai J Wewer Albrechtsen
Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes. Journal of the Endocrine Society 8 (4) (2024)
Sasha A S Kjeldsen, Mads N Thomsen, Mads J Skytte, Amirsalar Samkani, Michael M Richter, Jan Frystyk, Faidon Magkos, Elizaveta Hansen, Henrik S Thomsen, Jens J Holst, Sten Madsbad, Steen B Haugaard, Thure Krarup, Nicolai J Wewer Albrechtsen
Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes. Journal of the Endocrine Society 7 (11) (2023)
Yeliz Bulut, Niels Høegh Brandt-Jacobsen, Laust Frisenberg Buhl, Morten Schou, Jan Frystyk, Caroline Kistorp, Jon Jarløv Rasmussen
Persistently decreased quality of life and its determinants in previous illicit androgen users. The Journal of clinical endocrinology and metabolism (2023)
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H Birkebæk, Jan Frystyk
Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European journal of pediatrics 182 (2) (2022)
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H Birkebæk, Jan Frystyk
Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European journal of pediatrics 182 (2) (2022)
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H Birkebæk, Jan Frystyk
Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European journal of pediatrics 182 (2) (2022)
Mads N Thomsen, Mads Juul Skytte, Amirsalar Samkani, Martin H Carl, Philip Weber, Arnie Astrup, Elizaveta Chabanova, Mogens Fenger, Jan Frystyk, Bolette Hartmann, Jens Juul Holst, Thomas Meinert Larsen, Sten Madsbad, Faidon Magkos, Henrik S Thomsen, Steen B Haugaard, Thure Krarup
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 65 (3) (2022)
David Haldrup, Chunshan Wei, Peter Holland-Fischer, Kurt Kristensen, Søren Rittig, Aksel Lange, Arne Hørlyck, Jan Solvig, Henning Grønbæk, Niels H Birkebæk, Jan Frystyk
Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European journal of pediatrics (2022)
Louise Lehmann Christensen, Dorte Glintborg, Tine Taulbjerg Kristensen, Axel Cosmus Pyndt Diederichsen, Guy T'Sjoen, Jan Frystyk, Marianne Skovsager Andersen
Masculinising testosterone treatment and effects on preclinical cardiovascular disease, muscle strength and power, aggression, physical fitness and respiratory function in transgender men: protocol for a 10-year, prospective, observational cohort study in Denmark at the Body Identity Clinic (BIC). BMJ open 10 (12) (2020)
Ulrick Espelund, Andrew G Renehan, Søren Cold, Claus Oxvig, Lee Lancashire, Zhenqiang Su, Allan Flyvbjerg, Jan Frystyk
Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study. Cancer medicine 7 (6) (2018)